/term/rank-growth/STU:2UV Applied Therapeutics (STU:2UV) Growth Rank
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Applied Therapeutics Inc (STU:2UV) » Definitions » Growth Rank

Applied Therapeutics (STU:2UV) Growth Rank : 0 (As of Jun. 20, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Applied Therapeutics Growth Rank?

Applied Therapeutics has the Growth Rank of 0.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.


Applied Therapeutics Growth Rank Related Terms

Thank you for viewing the detailed overview of Applied Therapeutics's Growth Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Applied Therapeutics (STU:2UV) Business Description

Traded in Other Exchanges
Address
545 Fifth Avenue, Suite 1400, New York, NY, USA, 10017
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need.

Applied Therapeutics (STU:2UV) Headlines

No Headlines